Bereavement, exacerbated by losses stemming from the COVID-19 pandemic, contributes to high rates of grief and associated mood disturbances among older adults, potentially impacting neurocognition. Middle-old cohorts (ages 75-84) are particularly vulnerable, due to elevated levels of baseline depression, complicated grief, and perceived lower quality of life. The contributory role of grief and culturally-relevant manifestations of bereavement should be carefully considered as potential confounds or performance contributors. Four cases seen for neuropsychological assessment in the Department of Neurological Surgery: A 75-year-old bilingual (Russian, English) patient with a meningioma who noticed cognitive changes following spouse's death from COVID-19; A 77-year-old monolingual (English) patient with Parkinson's disease undergoing a pre-surgical work-up prior to Deep Brain Stimulator insertion. Mood reportedly worsened sharply since spouse's recent death; An 81-year-old monolingual (Cantonese) patient undergoing a pre-surgical work-up prior to DBS insertion. Shared grieving the recent death of younger sibling from COVID-19; An 84-year-old, monolingual (English) patient who was evaluated due to longstanding cognitive challenges in the context of cerebrovascular disease (monitored by Neurological Surgery). Cognitive deficits reportedly precipitously worsened following spouse's death. While levels of neurocognitive and adaptive dysfunction varied, mood disturbance and affective distress likely reduced engagement in the testing process. Reluctance to disclose depressive and anxious symptomatology on questionnaires as a function of culture was noted. Thorough, culturally-sensitive, clinical interviewing and metrics are needed to elicit nuanced information. Grief and associated mood disturbances are to be prioritized and carefully considered in the evaluation and treatment plan with middle-old older adults.
Read full abstract